Growth Metrics

Bruker (BRKR) Accumulated Expenses (2016 - 2025)

Bruker (BRKR) has disclosed Accumulated Expenses for 16 consecutive years, with $28.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 84.72% year-over-year to $28.7 million, compared with a TTM value of $28.7 million through Dec 2025, down 84.72%, and an annual FY2025 reading of $28.7 million, down 84.72% over the prior year.
  • Accumulated Expenses was $28.7 million for Q4 2025 at Bruker, down from $187.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $187.8 million in Q4 2024 and bottomed at $4.3 million in Q4 2023.
  • Average Accumulated Expenses over 5 years is $97.8 million, with a median of $132.0 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses crashed 96.84% in 2023, then skyrocketed 4267.44% in 2024.
  • Year by year, Accumulated Expenses stood at $132.0 million in 2021, then grew by 3.11% to $136.1 million in 2022, then plummeted by 96.84% to $4.3 million in 2023, then surged by 4267.44% to $187.8 million in 2024, then tumbled by 84.72% to $28.7 million in 2025.
  • Business Quant data shows Accumulated Expenses for BRKR at $28.7 million in Q4 2025, $187.8 million in Q4 2024, and $4.3 million in Q4 2023.